Cargando…

Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous Leukemia

The use of small molecules became one key cornerstone of targeted anti-cancer therapy. Among them, tyrosine kinase inhibitors (TKIs) are especially important, as they were the first molecules to proof the concept of targeted anti-cancer treatment. Since 2001, TKIs can be successfully used to treat c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaehler, Meike, Cascorbi, Ingolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273252/
https://www.ncbi.nlm.nih.gov/pubmed/34262462
http://dx.doi.org/10.3389/fphar.2021.696960

Ejemplares similares